Flexocam 7.5 And Flexocam 15 7.5 mg /15 mg Tablet
PDF Leaflet Revision Date: 13 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute sciatica.
Dosage (summary)
Max 15 mg/day; 7.5 mg for acute sciatica, 15 mg for ankylosing spondylitis and rheumatoid arthritis.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; may impair fertility.
Key Drug Interactions
- Lithium
- Methotrexate
- Anticoagulants
- Diuretics
Contraindications
- Hypersensitivity to meloxicam
- Active peptic ulcer disease
- Severe renal impairment
- Pregnancy
- Breastfeeding
Common side effects
- Gastrointestinal bleeding
- Dyspepsia
- Headache
- Dizziness
- Peripheral edema
Counselling Points
- Take with food and water
- Report unusual abdominal symptoms
- Avoid alcohol
- Monitor for signs of bleeding
Serious warnings
- Increased risk of cardiovascular events
- Gastrointestinal perforation
- Serious skin reactions
Important Disclaimer
The Flexocam 7.5 And Flexocam 15 7.5 mg /15 mg Tablet professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
